Free Trial
NYSE:EHAB

Enhabit (EHAB) Stock Price, News & Analysis

Enhabit logo
$7.71 -0.17 (-2.16%)
Closing price 03:59 PM Eastern
Extended Trading
$7.81 +0.10 (+1.28%)
As of 06:27 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Enhabit Stock (NYSE:EHAB)

Key Stats

Today's Range
$7.55
$7.98
50-Day Range
$7.52
$10.80
52-Week Range
$6.85
$10.91
Volume
1.76 million shs
Average Volume
467,476 shs
Market Capitalization
$390.43 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$8.75
Consensus Rating
Moderate Buy

Company Overview

Enhabit Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
41st Percentile Overall Score

EHAB MarketRank™: 

Enhabit scored higher than 41% of companies evaluated by MarketBeat, and ranked 838th out of 936 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Enhabit has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 1 buy rating, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    Enhabit has received no research coverage in the past 90 days.

  • Read more about Enhabit's stock forecast and price target.
  • Earnings Growth

    Earnings for Enhabit are expected to grow by 31.82% in the coming year, from $0.22 to $0.29 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Enhabit is -2.78, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Enhabit is -2.78, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Enhabit has a P/B Ratio of 0.71. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Enhabit's valuation and earnings.
  • Percentage of Shares Shorted

    3.05% of the float of Enhabit has been sold short.
  • Short Interest Ratio / Days to Cover

    Enhabit has a short interest ratio ("days to cover") of 3.6, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Enhabit has recently decreased by 2.19%, indicating that investor sentiment is improving.
  • Dividend Yield

    Enhabit does not currently pay a dividend.

  • Dividend Growth

    Enhabit does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    3.05% of the float of Enhabit has been sold short.
  • Short Interest Ratio / Days to Cover

    Enhabit has a short interest ratio ("days to cover") of 3.6, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Enhabit has recently decreased by 2.19%, indicating that investor sentiment is improving.
  • News Sentiment

    Enhabit has a news sentiment score of -0.72. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.90 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Enhabit this week, compared to 2 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Enhabit insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 3.40% of the stock of Enhabit is held by insiders.

  • Read more about Enhabit's insider trading history.
Receive EHAB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Enhabit and its competitors with MarketBeat's FREE daily newsletter.

EHAB Stock News Headlines

Dalio heeds Buffett’s warning… [$319 million stake in gold]
Dalio bought a gold ETF… I don’t recommend that for the average retail investor. The real upside is in profitable miners selling at deep discounts. I call this price gap the Golden Anomaly — and I’ve put together a full report on my top four picks.
See More Headlines

EHAB Stock Analysis - Frequently Asked Questions

Enhabit's stock was trading at $7.81 on January 1st, 2025. Since then, EHAB shares have decreased by 1.3% and is now trading at $7.71.
View the best growth stocks for 2025 here
.

Enhabit, Inc. (NYSE:EHAB) released its quarterly earnings data on Wednesday, May, 7th. The company reported $0.10 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.07 by $0.03. The company earned $259.90 million during the quarter, compared to analysts' expectations of $266.11 million. Enhabit had a positive trailing twelve-month return on equity of 2.02% and a negative net margin of 13.43%.
Read the conference call transcript
.

Shares of EHAB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Enhabit investors own include Alphabet (GOOG), Tesla (TSLA), JPMorgan Chase & Co. (JPM), Advanced Micro Devices (AMD), Netflix (NFLX), Home Depot (HD) and Meta Platforms (META).

Company Calendar

Last Earnings
5/07/2025
Today
7/02/2025
Next Earnings (Estimated)
8/05/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Medical Services
Sub-Industry
Healthcare
Current Symbol
NYSE:EHAB
Fax
N/A
Employees
10,700
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$8.75
High Stock Price Target
$9.50
Low Stock Price Target
$8.00
Potential Upside/Downside
+13.6%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
2 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
35.02
P/E Growth
N/A
Net Income
-$156.20 million
Pretax Margin
-12.98%

Debt

Sales & Book Value

Annual Sales
$1.03 billion
Cash Flow
$3.26 per share
Price / Cash Flow
2.36
Book Value
$10.92 per share
Price / Book
0.71

Miscellaneous

Free Float
48,915,000
Market Cap
$390.18 million
Optionable
Optionable
Beta
1.72
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

This page (NYSE:EHAB) was last updated on 7/2/2025 by MarketBeat.com Staff
From Our Partners